Second, private and public coverage is being restrained by worries about affordability
TABLE 2 Clinical characteristics of patients with GLP-1 receptor agonists-associated acute pancreatitis collected from the FAERS database (January 2005 to September 2023)
Currently, there is an increasing trend of switching between these medications for potentially improved outcomes
It is majorly found circulating in the blood as GLP-1(7-36) amide that is produced primarily from three tissues of the human body: enteroendocrine L cells in the distal small bowel, cells in the pancreas, and the central nervous system ( Surprisingly, it took approximately 20 years from the discovery of GLP-1 to the authorized approval of worldwide utilized GLP-1 RAs
Pharmacoeconomic evaluation in the real world
Intravenous therapy, or IV therapy, introduces the molecule directly into the bloodstream and ensures complete and immediate absorption, with generally faster effects